Adenocaine is a cardioprotective cardioplegia from Hibernation Therapeutics
Additional Compounds
Additional Compounds
Hibernation Therapeutic's has a broad range of compositions covered by the issued and pending patents in its extensive intellectual property portfolio. Hibernation Therapeutics is working to develop new uses and applications for different formulations of the Adenocaine™ technology. Clinical trials will be an integral part of this development process.
If you are interested in working with us, please contact us directly.
 |
